Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway
|更新时间:2024-06-14
|
Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway
“The latest research has found that Guishen Pill improves ovarian function in rats with follicular dysplasia by inhibiting the AMPK/mTOR/HIF-1/VEGF pathway, and its therapeutic effect is superior to other traditional Chinese medicine formulas, revealing the attribute of kidney essence deficiency syndrome.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 14, Pages: 46-54(2024)
HU Yingying,LIN Xuejuan,ZHUO Zushun,et al.Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(14):46-54.
HU Yingying,LIN Xuejuan,ZHUO Zushun,et al.Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(14):46-54. DOI: 10.13422/j.cnki.syfjx.20240705.
Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway